Perspectives on bifidobacteria as biotherapeutic agents in gastrointestinal health

Digestive Diseases and Sciences

Volumn 44, Issue 8, 1999, Pages 1499-1505

  Duffy, Linda C ^a,b   Leavens, Allen ^a   Griffiths, Elizabeth ^a   Dryja, Diane ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Bacterial translocation; Bifidobacteria; Prebiotics; Probiotics

Indexed keywords

ENDOTOXIN; PROBIOTIC AGENT;

BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; BIOLOGICAL THERAPY; BREAST FEEDING; CLOSTRIDIUM DIFFICILE; ENTERIC FEEDING; GASTROENTERITIS; GASTROINTESTINAL INFECTION; HUMAN; INFECTION RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS BIFIDUS; NECROTIZING ENTERITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; BIOLOGICAL THERAPY; ENTERAL NUTRITION; GASTROINTESTINAL DISEASES; HUMANS; INFECTION; INTESTINES; PERMEABILITY;

EID: 0032879671     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026632704628     Document Type: Review

References (60)

1. Cummings JH, Macfarlane GT: A review: the control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70:443-459, 1991
2. Elmer GW, Surawicz CM, McFarland LV: Biotherapeutic agents: A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275(11):870-876, 1996
3. Fuller R, Gibson GR: Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol 32(suppl 222):28-31, 1997
4. Salminen S, Isolauri E, Salminen E: Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges. Antonie van Leeuwenhock 70:347-358, 1996
5. Walker WA, Duffy LC: Diet and bacterial colonization: Role of probiotics and prebiotics. J Nutr Biochem 9(12):668-675, 1998
6. Schriffin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A: Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66(2):5155-5205, 1997
7. Gorbach SL: Lactic acid bacteria and human health. Ann Med 22:37-41, 1990
8. Berg RD: Translocation of indigenous bacteria from the intestinal tract. In Human Intestinal Microflora in Health and Disease. Orlando, Florida, Academic Press, 1983, pp 333-352
9. Steffan EK, Berg RD, Deitch EA: Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 157:1032-1038, 1988
10. Ford HR, Avanoglu A, Boechat PR, Melgoza D, Lumcheong RS, Boyle P, Garrett M, Rowe MI: The microenvironment influences the pattern of bacterial translocation in formula-fed neonates. J Pediatr Surg 31(4):486-489, 1996
11. Go LL, Ford HR, Watkins SC, Healey PJ, Albanese CT, Donhalek A, Simmons RL, Rowe MI: Quantitative and morphologic analysis of bacterial translocation in neonates. Arch Surg 129(11):1184-1190, 1994
12. Wells CL, Maddaus MA, Simmons RL: Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 10(5):958-979, 1988
13. Katouli M, Nettbladt CG, Muratov V, LJungOVist O, Bark T, Svenberg T, Mollby R: Selective translocation of coliform bacteria adhering to caecal epithelium of rats during catabolic stress. J Med Microbiol 46:571-578, 1997
14. Albanese CT, Smith SD, Watkins S, Kurkchubasche A, Simmons RL, Rowe MI: Effect of secretory IgA on transepithelial passage of bacteria across the intact ileum in vitro. J Am Coll Surg 179(6):679-688, 1994
15. Vandengergh PA: Lactic acid bacteria, their metabolic products, and interference with microbial growth. FEMS Microbiol Rev 12:221-238, 1993
16. Katayawa M, Dazhong X, Specian R, Deitch E: Role of bacterial adherence and the mucous barrier on bacterial translocation. Ann Surg 225(3):317-326. 1997
17. Metchnikoff E: The Prolongation of Life. London, William Heinemann, 1907
18. Tissier H: Repartition des microbes dans I'intestin du nourisson. Ann Inst Pasteur 19:109-115, 1905
19. Bezkorovainy A: Classification of Bifidobacteria. In Biochemistry and Physiology of Bifidobacteria. A Bezkorovainy, Robin Miller-Catchpole (eds). Boca Raton, Florida, CRC Press, 1989, pp 1-29
20. McBain AJ, MacFarlane GT: Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-state compound continuous culture system. Scand J Gastroenterol S222:32-40, 1997
21. Mitsuoka T: Taxonomy and ecology of bifidobacteria. Bifid Microflora 3:11-28, 1984
22. Wang X, Gibson GR: Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75:373-380, 1993
23. Noda H, Akasaka N, Ohsugi M: Biotin production by bifidobacteria. J Nutr Sci Vitaminol 40(2):181-188, 1994
24. Kunz C, Rudloff S: Biological functions of oligosaccharides in human milk. Acta Paediatr 82(11):903-912, 1993
25. Neter E: Microflora patterns in breast-fed and artificially-fed infants. In Textbook of Gastroenterology and Nutrition in Infancy. E Lebanthal (ed). New York, Raven Press, 1994, Chap 22
26. Hentges D: Gut flora and disease resistance. In Probiotics: The Scientific Basis. R Fuller (ed). New York, Chapman & Hall, 1992, pp 87-109
27. Wells CL, Maddaus MA, Jechorek RP, Simmons RL: Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 7(1):107-113, 1988
28. Beach RC, Menzies IS, Clayden GS, Scopes JW: Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child 57:141-145, 1982
29. Tannock GW: Probiotic properties of lactic-acid bacteria: Plenty of scope for fundamental R & D. Trends Biotech 15(7)270-274, 1997
30. Goldin BR, Gorbach SL: Probiotics for humans. In Probiotics: The Scientific Basis. R Fuller (ed). London, Chapman & Hall, 1992, pp 355-376
31. Walker WA: The role of the mucosal barrier in toxin/microbial interaction. CIBA Found Symp 112:37-47, 1985
32. McFarland LV, Elmer GW: Biotherapeutic agents: Past, present and future. Microecology Ther 23:46-73, 1995
33. Deitch EA: Bacterial translocation of the gut flora. J Trauma 30(suppl):S184-S189, 1990
34. Shu-Heh, Chu W, Walker WA: Bacterial toxin interaction with the developing intestine. Gastroenterology 104:916-925, 1993
35. Dharakul T, Riepenhoff-Talty M, Albini B, Ogra PL: Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol 74:14-19, 1998
36. Osborne MP, Haddon SJ, Spencer AJ, Collins J, Starkey WG, Wallis TS, Clarke GJ, Worton KJ, Candy DC, Stephen J: An electron microscopic investigation of time-related changes in the intestine of neonatal mice infected with murine rotavirus. J Pediatr Gastroenterol Nutr 7(2):236-248, 1988
37. Duffy, LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Griffiths E, Ruffin D, Barrett H, Ogra PL: Reduction of virus shedding by B. bifidum in experimentally induced MRV infection. Dig Dis Sci 39(11):2334-2340, 1994
38. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344:1046-1049, 1994
39. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H: Enhancement of the circulating antibody secreting cell respsonse in human diarrhea by a human Lactobacillus strain. Pediatr Res 32:141-144, 1992
40. Biller JA, Katz AJ, Flores AF, Buic TM, Gorbach SL: Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 21:224-226, 1995
41. Naaber P, Mikelsaar RH, Salminen S, Mikelsaar M: Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. J Med Microbiol 47(7):591-598, 1998
42. Lewis SJ, Freedman AR: Review article: The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 12(9):807-822, 1998
43. Fuller R: Probiotics in human medicine. Gut 32:439-442, 1991
44. Ewe K, Wanitscke R, Staritz M: Intestinal permeability studies in humans. In Pharmacology of Intestinal Permeation II. TZ Csaky (ed). New York, Springer-Verlag, 1984, pp 535-571
45. Wells CL, Maddaus, MA, Simmons RL: Role of the macrophage in the translocation of intestinal bacteria. Arch Surg 122:48-53, 1987
46. Pool-Zobel BL, Bertram B, Knoll M, Lambertz R, Neudecker C, Schillinger U, Schmezer P, Holzapfel WH: Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr Cancer 20(3):271-281, 1993
47. Wilson KH, Perini F: Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immunol 56:2610-2614, 1988
48. Weinberg ED: Iron withholding: A defense against infection and neoplasia. Physiol Rev 64(1):65-102, 1984
49. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M: Identification of the bacteríocidal domain of lactoferrin. Biochim Biophys Acta 1121(1-2):130-136, 1992
50. Rasic J, Kurmann J: Bifidobacteria and their role. Experentia (Suppl) 39:1-295, 1983
51. Santulli TV, Shullinger JN, Heird WC, Gongaware RD, Wigger J, Barlow B, Touloukian RJ, Amoury RA: Acute necrotizing enterocolitis in infancy: A review of 64 cases. Pediatrics 55:376-387, 1975
52. Duffy LC, Zielezny MA, Carrion V, Griffiths E, Dryja D, Hilty M, Cummings J, Morin F: Bacterial toxins and enteral feeding of premature infants at risk for necrotizing enterocolitis. Am J Hum Biol 10:211-219, 1998
53. Duffy LC, Zielezny MA, Carrion V, Griffiths E, Dryja D, Hilty M, Rook C, Morin F: Concordance of bacterial cultures with endotoxin and interleukin-6 in necrotizing enterocolitis. Dig Dis Sci 42(2):359-365, 1997
54. Gibson GR, Beatty EB, Wang X, Cummings JH: Selective stimulation of Bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975-982, 1995
55. Lee YK, Salminen S: The coming of age of probiotics. Trends Food Sci Technol 6:241-245, 1995
56. Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 125(6):1401-1412, 1995
57. Roberfroid MB: Functional effects of food components and the gastrointestinal system: Chicory fructooligosaccharides. Nutr Rev 54(11):538-542, 1996
58. Howard MD, Gordon DT, Garleb KA, Kerley MS: Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. J Nutr 125(10):2604-2609, 1995
59. De Vuyst L, Vandamme EJ (eds): Bacteriocins of Lactic Acid Bacteria. Glasgow, Blackie Academic and Professional, 1994
60. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A: Immunomodulation of human blood cells following ingestion of lactic acid bacteria. J Dairy Sci 78(3):491-497, 1995